Start a Technology to collaborate on new research.
Technologies are open to all Therapoid members, subject to the our Terms of Service (TOS). You can utilize these technologies in your research free of charge with other Therapoid users.
oncolytic herpes simplex virus (oHSV)-rQT3 against cancer cells
Open Therapeutics™; Research Institute Nationwide Children's Hospital
Engineered oHSV lytically destroy cancer cells and stimulates the immune system to act against cancer cells.Tags: oncolytics cancer immunotherapy virus